Ivan Gazid is diagnosed with throat cancer

Former Arsenal manager Ivan Gazidis has been diagnosed with throat cancer, although doctors expect him to have a full recovery.

Gazidis spent ten years with the Gunners before leaving the club in 2018 to become CEO of Milan – a role he still holds today.

Milan went to their official website to reveal the news and sent their best wishes to Gazidis while offering the brighter news that doctors expect him to have a full recovery.

“AC Milan inform their fans and stakeholders that our CEO, Ivan Gazidis, has been diagnosed with a throat cancer,” the statement said. “Based on an extensive series of tests and scans, doctors expect him to make a complete recovery.

Ivan will remain operational during the necessary treatment in specialized clinics, with the full support of the ownership, President Scaroni and the club’s management. Everyone involved in the club wishes Ivan all the best for a complete and speedy recovery. We are all with you. ”

Gazidis also took the opportunity to make a brief statement, saying he is confident of making a full recovery and appealing to others to ensure they receive regular checks.

“Of course, there is never a good time for a cancer diagnosis, but I have a very curable form of cancer and a positive diagnosis,” he wrote.

“I have world – class medical expertise and the support of so many loved ones and everyone at the club, and I am confident in all advice that cancer will be treated successfully, with full recovery.

“My diagnosis shows the importance of regular medical check-ups, even if you have no symptoms. I encourage everyone to prioritize their health and make sure, even in the daily responsibilities of life and work, that they have their regular medical check-ups.

“We have a strong team, both on and off the pitch, and I have full faith in their ability to drive our club forward in the coming weeks. See you soon and always Forza Milan.”

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More